Company / Gross Margin
cbdMD, Inc. Gross Margin History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
61.6%
FY2025
5-year range
61.6% / 67.4%
FY2021-FY2025
Trend
-0.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Margin has declined for 3 consecutive years, from 67.4% in FY2022 to 61.6% in FY2025.
Based on SEC 10-K filings.
61.6% in FY2025 with a 5-year CAGR of +0.2%.
Declined from 63.1% to 61.6% over the past 2 years.
Gross Margin over time
Growth rates
- 3-Year Change
- -5.8pp
- 5-Year Change
- +0.2pp
- 10-Year Change
- -
Key checks
Key Insights
- cbdMD, Inc.'s gross margin has declined for 3 consecutive years.
- In FY2025, gross margin decreased 0.7% year-over-year.
- Peak gross margin was recorded in FY2019.
- Lowest gross margin in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 1.21 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 61.6% | -0.7% |
| FY2024 | 62.0% | -1.7% |
| FY2023 | 63.1% | -6.4% |
| FY2022 | 67.4% | +7.1% |
| FY2021 | 63.0% | +2.6% |
| FY2020 | 61.4% | -20.6% |
| FY2019 | 77.3% | +10.9% |
| FY2018 | 69.7% | +242.7% |
| FY2017 | 20.3% | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026